Differential gene expression in the proximal neck of human abdominal aortic aneurysm

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 211-218

  Biros, Erik ^a   Moran, Corey S ^a   Rush, Catherine M ^a   Gäbel, Gabor ^b   Schreurs, Charlotte ^c   Lindeman, Jan H N ^c   Walker, Philip J ^d   Nataatmadja, Maria ^e   West, Malcolm ^e   Holdt, Lesca M ^b   Hinterseher, Irene ^f   Pilarsky, Christian ^b   Golledge, Jonathan ^a,g  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF MUNICH   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Abdominal; Aortic aneurysm; B lymphocytes; Inflammation; Tissue array analysis

Indexed keywords

ABDOMINAL; AORTIC ANEURYSM; B-LYMPHOCYTES; INFLAMMATION; TISSUE ARRAY ANALYSIS;

ADULT; AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; TRANSCRIPTOME; UP-REGULATION;

EID: 84893839636     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.017     Document Type: Article

References (39)

1. Schumacher H., Eckstein H.H., Kallinowski F., Allenberg J.R. Morphometry and classification in abdominal aortic aneurysms: patient selection for endovascular and open surgery. JEndovasc Surg 1997, 4(1):39-44.
2. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26(12):2605-2613.
3. Golledge J., Norman P.E. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 2011, 217(1):57-63.
4. Trollope A., Moxon J.V., Moran C.S., Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol 2011, 20(2):114-123.
5. Lenk G.M., Tromp G., Skunca M., Gatalica Z., Berguer R., Kuivaniemi H. Global expression profiles in human normal and aneurysmal abdominal aorta based on two distinct whole genome microarray platforms. Ann N Y Acad Sci 2006, 1085:360-362.
6. Lenk G.M., Tromp G., Weinsheimer S., Gatalica Z., Berguer R., Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007, 8:237.
7. Choke E., Cockerill G.W., Laing K., et al. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2009, 37(3):305-310.
8. Golledge J., Clancy P., Moran C., et al. The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am J Pathol 2010, 176(5):2098-2106.
9. Biros E., Norman P.E., Walker P.J., Nataatmadja M., West M., Golledge J. Asingle nucleotide polymorphism in exon 3 of the kallikrein 1 gene is associated with large but not small abdominal aortic aneurysm. Atherosclerosis 2011, 217(2):452-457.
10. Golledge A.L., Walker P., Norman P.E., Golledge J. Asystematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples. Dis Markers 2009, 26(4):181-188.
11. Golledge J., Norman P.E. Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management. Curr Opin Cardiol 2009, 24(6):532-538.
12. Lindeman J.H., Rabelink T.J., van Bockel J.H. Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde?. Circulation 2011, 124(18):e463-e465.
13. Meijer C.A., Le Haen P.A., van Dijk R.A., et al. Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study. Clin Sci (Lond) 2012, 122(9):421-428.
14. Golledge J., Clancy P., Jamrozik K., Norman P.E. Obesity, adipokines, and abdominal aortic aneurysm: health in men study. Circulation 2007, 116(20):2275-2279.
15. Parr A., Buttner P., Shahzad A., Golledge J. Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol 2010, 105(6):895-899.
16. Parr A., McCann M., Bradshaw B., Shahzad A., Buttner P., Golledge J. Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. JVasc Surg 2011, 53(1):28-35.
17. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-W748.
18. Kuivaniemi H., Platsoucas C.D., Tilson M.D. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008, 117(2):242-252.
19. Golledge J. Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem?. Arterioscler Thromb Vasc Biol 2013, 33(4):670-672.
20. Ware C.F., Crowe P.D., Grayson M.H., Androlewicz M.J., Browning J.L. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. JImmunol 1992, 149(12):3881-3888.
21. Gräbner R., Lötzer K., Döpping S., et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. JExp Med 2009, 206(1):233-248.
22. Kratz A., Campos-Neto A., Hanson M.S., Ruddle N.H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. JExp Med 1996, 183(4):1461-1472.
23. Kendall P.L., Yu G., Woodward E.J., Thomas J.W. Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes. JImmunol 2007, 178(9):5643-5651.
24. Gregory A.K., Yin N.X., Capella J., Xia S., Newman K.M., Tilson M.D. Features of autoimmunity in the abdominal aortic aneurysm. Arch Surg 1996, 131(1):85-88.
25. Rush C., Nyara M., Moxon J.V., Trollope A., Cullen B., Golledge J. Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm. BMC Genomics 2009, 10:298.
26. Spin J.M., Hsu M., Azuma J., et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Genomics 2011, 43(17):993-1003.
27. Gatumu M.K., Skarstein K., Papandile A., Browning J.L., Fava R.A., Bolstad A.I. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther 2009, 11(1):R24.
28. Fava R.A., Kennedy S.M., Wood S.G., et al. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome. Arthritis Res Ther 2011, 13(6):R182.
29. Hanson R.G., Peters M.G., Hoofnagle J.H. Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology 1986, 6(2):173-179.
30. Britton S., Palacios R. Cyclosporin A-usefulness, risks and mechanism of action. Immunol Rev 1982, 65:5-22.
31. Karnell J.L., Karnell F.G., Stephens G.L., et al. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. JImmunol 2011, 187(7):3603-3612.
32. Walport M., Murphy K., Janeway C., Travers P.J. Janeway's immunobiology 2008, Garland Science, New York. 7th ed.
33. Tonnessen B.H., Sternbergh W.C., Money S.R. Late problems at the proximal aortic neck: migration and dilation. Semin Vasc Surg 2004, 17(4):288-293.
34. Sampaio S.M., Panneton J.M., Mozes G., et al. Aortic neck dilation after endovascular abdominal aortic aneurysm repair: should oversizing be blamed?. Ann Vasc Surg 2006, 20(3):338-345.
35. Diehm N., Dick F., Katzen B.T., Schmidli J., Kalka C., Baumgartner I. Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: a word of caution. JVasc Surg 2008, 47(4):886-892.
36. Browning J.L. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol Rev 2008, 223:202-220.
37. Takahashi N., de Jager V.C., Glück A., et al. The molecular signature of oxidative metabolism and the mode of macrophage activation determine the shift from acute to chronic disease in experimental arthritis: critical role of interleukin-12p40. Arthritis Rheum 2008, 58(11):3471-3484.
38. Diehm N., Di Santo S., Schaffner T., et al. Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck. JVasc Surg 2008, 48(2):425-434.
39. Dorshkind K., Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 2009, 21(4):404-407.